See more : Vertu Motors plc (VTU.L) Income Statement Analysis – Financial Results
Complete financial analysis of Healthcare Capital Corp. (HCCC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthcare Capital Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- V.S.T. Tillers Tractors Limited (VSTTILLERS.BO) Income Statement Analysis – Financial Results
- CAVU Energy Metals Corp. (CAVU.CN) Income Statement Analysis – Financial Results
- Allied Properties Real Estate Investment Trust (APYRF) Income Statement Analysis – Financial Results
- FreeBit Co., Ltd. (3843.T) Income Statement Analysis – Financial Results
- Catcha Investment Corp (CHAAW) Income Statement Analysis – Financial Results
Healthcare Capital Corp. (HCCC)
About Healthcare Capital Corp.
As of March 7, 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd., in a reverse merger transaction. Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 6.82M | 7.55M | 6.35M | 20.93K |
| Cost of Revenue | 0.00 | 4.85M | 5.53M | 4.33M | 20.51K |
| Gross Profit | 0.00 | 1.96M | 2.01M | 2.02M | 418.00 |
| Gross Profit Ratio | 0.00% | 28.79% | 26.68% | 31.86% | 2.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.00K |
| General & Administrative | 0.21 | 2.34M | 2.37M | 1.78M | 476.83K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.21 | 2.34M | 2.37M | 1.78M | 476.83K |
| Other Expenses | 0.10 | 80.50K | 78.00K | 184.00K | 0.00 |
| Operating Expenses | 0.31 | 2.42M | 2.45M | 1.96M | 478.83K |
| Cost & Expenses | 0.31 | 7.27M | 7.98M | 6.29M | 499.34K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | -0.04 | 42.90K | 106.21K | 0.00 | 0.00 |
| Depreciation & Amortization | 50.46K | 349.80K | 194.11K | 32.59K | 600.00 |
| EBITDA | 50.46K | -318.70K | -237.44K | 95.54K | -477.82K |
| EBITDA Ratio | 0.00% | -4.67% | -3.15% | 1.50% | -2,283.25% |
| Operating Income | -0.31 | -453.34K | -433.41K | 62.95K | -478.42K |
| Operating Income Ratio | 0.00% | -6.65% | -5.74% | 0.99% | -2,286.11% |
| Total Other Income/Expenses | -1.10 | -258.05K | -104.35K | 0.00 | 0.00 |
| Income Before Tax | -1.41 | -711.39K | -537.75K | 62.95K | -478.42K |
| Income Before Tax Ratio | 0.00% | -10.44% | -7.13% | 0.99% | -2,286.11% |
| Income Tax Expense | -1.14 | 13.00K | 16.26K | 54.06K | 0.00 |
| Net Income | -1.41 | -724.39K | -554.01K | 8.90K | -478.42K |
| Net Income Ratio | 0.00% | -10.63% | -7.34% | 0.14% | -2,286.11% |
| EPS | 0.00 | -0.09 | -0.07 | 0.00 | -0.17 |
| EPS Diluted | 0.00 | -0.09 | -0.07 | 0.00 | -0.17 |
| Weighted Avg Shares Out | 7.64M | 7.64M | 7.59M | 6.70M | 2.85M |
| Weighted Avg Shares Out (Dil) | 7.64M | 7.64M | 7.59M | 7.70M | 2.85M |
Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer
Source: https://incomestatements.info
Category: Stock Reports